Are statins a valid approach for preventing contrast-induced nephropathy (CIN)?

Patients treated with statins have a significant 55% decreased odds of nephropathy.
Patients treated with statins have a significant 55% decreased odds of nephropathy.

A new meta-analysis published online ahead of print in the American Journal of Therapeutics found that the patients treated with statins prior to interventional procedures requiring administration of iodinated contrast media have a significant 55% decreased odds of contrast-induced nephropathy (CIN).

The meta-analysis, by Alexandros Briasoulis, MD, PhD, of Wayne State University/Detroit Medical Center, and colleagues, included 9 prospective randomized trials of high-dose statin treatment compared with placebo for CIN prevention in a total of 2,480 statin recipients and 2,504 controls.

Renal & Urology News would like to ask nephrologists the following poll question:

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters